Cite
HARVARD Citation
Kucharzik, T. et al. (n.d.). S902 Intestinal Ultrasound Response and Transmural Remission After 48 Weeks of Treatment With Ustekinumab in Crohn's Disease: STARDUST Trial Substudy Results by Line of Treatment and by Location. American journal of gastroenterology. p. S426. [Online].